{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:39:28Z","timestamp":1789695568991,"version":"4.0.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018557","name":"Science and Technology Project of Nantong City","doi-asserted-by":"publisher","award":["JC2021059"],"award-info":[{"award-number":["JC2021059"]}],"id":[{"id":"10.13039\/501100018557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872853"],"award-info":[{"award-number":["81872853"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005054","name":"Nantong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.expneurol.2023.114337","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T19:41:12Z","timestamp":1674848472000},"page":"114337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Passive immunization inhibits tau phosphorylation and improves recognition learning and memory in 3xTg-AD mice"],"prefix":"10.1016","volume":"362","author":[{"given":"Longfei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ling","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2023.114337_bb0005","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/awz100","article-title":"Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody","volume":"142","author":"Albert","year":"2019","journal-title":"Brain."},{"key":"10.1016\/j.expneurol.2023.114337_bb0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0796-783","article-title":"Alzheimer\u2019s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules","volume":"2","author":"Alonso","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2023.114337_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology."},{"key":"10.1016\/j.expneurol.2023.114337_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb2639","article-title":"Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer\u2019s disease","volume":"13","author":"Ayalon","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2023.114337_bb0025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer\u2019s disease","volume":"26","author":"Barthelemy","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2023.114337_bb0030","series-title":"Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice. 1474-9718","volume":"18","author":"Belfiore","year":"2019"},{"key":"10.1016\/j.expneurol.2023.114337_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.462299","article-title":"Development of immunoprecipitation - two-dimensional liquid chromatography - mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients","volume":"1651","author":"Bijttebier","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.expneurol.2023.114337_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","article-title":"Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains","volume":"129","author":"Boluda","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2023.114337_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2010.10.009","article-title":"Sex differences in beta-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure","volume":"1366","author":"Carroll","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2023.114337_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104855","article-title":"Neuronal circuitry for recognition memory of object and place in rodent models","volume":"141","author":"Chao","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.expneurol.2023.114337_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan8821","article-title":"Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model","volume":"361","author":"Choi","year":"2018","journal-title":"Science."},{"key":"10.1016\/j.expneurol.2023.114337_bb0065","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1021\/acschemneuro.8b00457","article-title":"Pathological changes of tau related to Alzheimer\u2019s disease","volume":"10","author":"Chu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"2140\u20132149","key":"10.1016\/j.expneurol.2023.114337_bb0070","article-title":"Filamentous aggregates are fragmented by the proteasome holoenzyme","volume":"26","author":"Cliffe","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2023.114337_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-019-02087-9","article-title":"From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy","volume":"139","author":"Colin","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0080","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1093\/brain\/awu213","article-title":"Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer's disease","volume":"137","author":"Collin","year":"2014","journal-title":"Brain."},{"key":"10.1016\/j.expneurol.2023.114337_bb0085","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0090","doi-asserted-by":"crossref","first-page":"35452","DOI":"10.1074\/jbc.M113.491001","article-title":"Antibody uptake into neurons occurs primarily via clathrin-dependent Fcgamma receptor endocytosis and is a prerequisite for acute tau protein clearance","volume":"288","author":"Congdon","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114337_bb0095","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","article-title":"Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies","volume":"122","author":"Dai","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.expneurol.2023.114337_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-016-0227-5","article-title":"Tau passive immunization inhibits not only tau but also Abeta pathology","volume":"9","author":"Dai","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2023.114337_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-018-0341-7","article-title":"Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated tau-induced pathology in 3 x Tg-AD mice","volume":"10","author":"Dai","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2023.114337_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag0481","article-title":"Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy","volume":"9","author":"DeVos","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.expneurol.2023.114337_bb0115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fnins.2018.00267","article-title":"Synaptic tau seeding precedes tau pathology in human Alzheimer\u2019s disease brain","volume":"12","author":"DeVos","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114337_bb0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41586-018-0454-y","article-title":"Structures of filaments from Pick's disease reveal a novel tau protein fold","volume":"561","author":"Falcon","year":"2018","journal-title":"Nature."},{"key":"10.1016\/j.expneurol.2023.114337_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer's disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.expneurol.2023.114337_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fnins.2014.00235","article-title":"New roles for fc receptors in neurodegeneration-the impact on immunotherapy for Alzheimer\u2019s disease","volume":"8","author":"Fuller","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114337_bb0135","doi-asserted-by":"crossref","first-page":"21652","DOI":"10.1074\/jbc.M115.657924","article-title":"Distinct therapeutic mechanisms of tau antibodies: promoting microglial clearance versus blocking neuronal uptake","volume":"290","author":"Funk","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114337_bb0140","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/pro.3499","article-title":"Soluble tau aggregates, not large fibrils, are the toxic species that display seeding and cross-seeding behavior","volume":"27","author":"Ghag","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.expneurol.2023.114337_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/alzrt233","article-title":"Open questions for Alzheimer\u2019s disease immunotherapy","volume":"6","author":"Golde","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2023.114337_bb0150","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114337_bb0155","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2023.114337_bb0160","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1074\/jbc.RA120.012587","article-title":"Truncation of tau selectively facilitates its pathological activities","volume":"295","author":"Gu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2023.114337_bb0165","article-title":"Morris water maze and contextual fear conditioning tasks to evaluate cognitive functions associated with adult hippocampal neurogenesis","volume":"15","author":"Hernandez-Mercado","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114337_bb0170","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(20)30489-0","article-title":"Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial","volume":"20","author":"Hoglinger","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0175","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jalz.2016.01.014","article-title":"Hyperphosphorylation determines both the spread and the morphology of tau pathology","volume":"12","author":"Hu","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2023.114337_bb0180","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/17460441.2018.1445084","article-title":"Recent developments with tau-based drug discovery","volume":"13","author":"Iqbal","year":"2018","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.expneurol.2023.114337_bb0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-018-1855-6","article-title":"Tau seeding activity begins in the transentorhinal\/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART","volume":"136","author":"Kaufman","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2023.114337_bb0195","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1007\/s12035-019-1507-4","article-title":"Pathological alterations of tau in Alzheimer\u2019s disease and 3xTg-AD mouse brains","volume":"56","author":"Li","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40478-021-01127-4","article-title":"Alzheimer's disease brain contains tau fractions with differential prion-like activities","volume":"9","author":"Li","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2023.114337_bb0205","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/cns.13970","article-title":"Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation","volume":"28","author":"Li","year":"2022","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.expneurol.2023.114337_bb0210","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.aat8789","article-title":"Adult-born hippocampal neurons bidirectionally modulate entorhinal inputs into the dentate gyrus","volume":"364","author":"Luna","year":"2019","journal-title":"Science."},{"key":"10.1016\/j.expneurol.2023.114337_bb0215","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1073\/pnas.1607215114","article-title":"Cytosolic Fc receptor TRIM21 inhibits seeded tau aggregation","volume":"114","author":"McEwan","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2023.114337_bb0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40478-017-0488-7","article-title":"What is the evidence that tau pathology spreads through prion-like propagation?","volume":"5","author":"Mudher","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2023.114337_bb0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-020-2156-5","article-title":"LRP1 is a master regulator of tau uptake and spread","volume":"580","author":"Rauch","year":"2020","journal-title":"Nature."},{"key":"10.1016\/j.expneurol.2023.114337_bb0230","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40478-020-0884-2","article-title":"Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease","volume":"8","author":"Roberts","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2023.114337_bb0235","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.1113694","article-title":"Tau suppression in a neurodegenerative mouse model improves memory function","volume":"309","author":"Santacruz","year":"2005","journal-title":"Science."},{"key":"10.1016\/j.expneurol.2023.114337_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4161\/mabs.23684","article-title":"Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human","volume":"5","author":"Shah","year":"2013","journal-title":"MAbs."},{"key":"10.1016\/j.expneurol.2023.114337_bb0245","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF00308476","article-title":"A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease","volume":"83","author":"Vallet","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00401-021-02301-7","article-title":"Tau strains shape disease","volume":"142","author":"Vaquer-Alicea","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2023.114337_bb0255","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/bit.23155","article-title":"Aggregates in monoclonal antibody manufacturing processes","volume":"108","author":"Vazquez-Rey","year":"2011","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.expneurol.2023.114337_bb0260","doi-asserted-by":"crossref","first-page":"15709","DOI":"10.1038\/srep15709","article-title":"Rapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylation","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2023.114337_bb0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40478-019-0770-y","article-title":"Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans","volume":"7","author":"Weisova","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.expneurol.2023.114337_bb0270","first-page":"236","article-title":"Preclinical and clinical development of ABBV-8E12, a humanized anti-tau antibody, for treatment of Alzheimer\u2019s disease and other Tauopathies","volume":"4","author":"West","year":"2017","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2023.114337_bb0275","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt237","article-title":"Active immunotherapy options for Alzheimer\u2019s disease","volume":"6","author":"Winblad","year":"2014","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.expneurol.2023.114337_bb0280","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1073\/pnas.85.12.4506","article-title":"Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease","volume":"85","author":"Wischik","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2023.114337_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2018.08.041","article-title":"Dynamic assessment of tau immunotherapies in the brains of live animals by two-photon imaging","volume":"35","author":"Wu","year":"2018","journal-title":"EBioMedicine."},{"key":"10.1016\/j.expneurol.2023.114337_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.631833","article-title":"Dephosphorylation passivates the seeding activity of oligomeric tau derived from Alzheimer\u2019s brain","volume":"14","author":"Wu","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2023.114337_bb0295","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","article-title":"Novel tau filament fold in corticobasal degeneration","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488623000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:54:21Z","timestamp":1762149261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488623000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":59,"alternative-id":["S0014488623000213"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114337","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Passive immunization inhibits tau phosphorylation and improves recognition learning and memory in 3xTg-AD mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2023.114337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114337"}}